P&G Health reports 26% net profit surge in Q2 amid robust revenue growth

Procter & Gamble Health Ltd reported significant profitability gains in its second quarter results, demonstrating the company's resilience in the competitive Indian consumer health sector. Net profit for the period surged 26% year-on-year to Rs 112 crore, reflecting improved operational efficiency and strong market demand.

The company's revenue expanded 18% during the quarter, signalling sustained consumer interest in its portfolio of health and wellness products. The topline growth was accompanied by margin expansion, with earnings before interest, tax, depreciation and amortisation (EBITDA) climbing 26.7% year-on-year to Rs 152 crore.

The parallel growth in both revenue and profitability metrics suggests the company has successfully managed cost pressures while scaling its distribution and marketing efforts. The results underscore P&G Health's strategic positioning in India's growing consumer health market, which has witnessed increased spending on preventive healthcare and wellness products in recent years.

With both profit and EBITDA expanding at rates exceeding revenue growth, the company has demonstrated improving operational leverage. The quarterly performance positions P&G Health favourably amid competitive pressures in India's consumer staples and health segments.